Search Results - Sheng L

A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma by Wang Z, Bao Y, Xu Z, Sun Y, Yan X, Sheng L, Ouyang G

Connect to this object online.

Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects by Wu J, Xu H, Li H, Ma L, Chen J, Yuan F, Sheng L, Liu C, Chen W, Li X

Connect to this object online.

Evaluation of Inflammatory Markers in Patients with COVID-19 Combined with Type 2 Diabetes Mellitus by Li J, Zhang Y, Wu R, Ma G, Sheng L, Feng Y, Han Y, Zhang L, Guo J, Li R

Connect to this object online.

Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects by Sheng L, Cao W, Lin P, Chen W, Xu H, Zhong C, Yuan F, Chen H, Li H, Liu C, Yang M, Li X

Connect to this object online.

A Simple System for Differentiation of Functional Intestinal Stem Cell-like Cells from Bone Marrow Mesenchymal Stem Cells by Lei Ye, Lei X. Sun, Min H. Wu, Jin Wang, Xin Ding, Hui Shi, Sheng L. Lu, Lin Wu, Juan Wei, Liang Li, Yu F. Wang

Connect to this object online.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of novel glucokinase activator HMS5552: results from a first-in-human single ascending dose study by Xu HR, Sheng L, Chen WL, Yuan F, Yang MJ, Li H, Li XN, Choi J, Zhao GY, Hu TX, Li YG, Zhang Y, Chen L

Connect to this object online.